—STLD
— • —
$193.31
P/E
24.17
PEG
—
FCF Yield
—
Rev Growth YoY
+363.0% YoY
Gross Margin
1316.0%
Health Score
6/10
D/E Ratio
0.47
Confidence
LOW
Business Snapshot
The ticker and exchange data are absent from this payload, which significantly limits contextual analysis. Based on the available financial data — including a current price of $193.31 and a Price/Sales ratio of 1.52x — this appears to be an operating company with meaningful revenue. Without a confirmed market capitalisation figure, the cap tier cannot be determined with certainty, though the valuation ratios suggest a mid-to-large scale enterprise.
Financial Health
**Score: 6/10** The balance sheet shows a conservative debt posture, with a Debt/Equity ratio of just 0.47x, indicating the company is not heavily leveraged. The current ratio of 3.06x is healthy, suggesting strong short-term liquidity — the company holds roughly $3 in liquid assets for every $1 of near-term obligations...
Risk Assessment
- **EARNINGS DETERIORATION:** Earnings growth of -1,830.0% YoY despite 363.0% revenue growth signals a severe disconnect between top-line performance and bottom-line health. - **CASH FLOW OPACITY:** Free cash flow data is entirely absent, making it impossible to verify whether reported net margins of 652.0% reflect real economic profit or accounting effects. - **TECHNICALS — DEATH CROSS:** The 50-day moving average has crossed below the 200-day moving average (a "death cross"), a bearish technical pattern suggesting near-term downward price momentum. - **VALUATION STRETCH:** EV/EBITDA of 61.92x is significantly elevated, implying the market is pricing in growth that is not yet visible in confirmed earnings or cash flow metrics. - **DATA COMPLETENESS:** The absence of a confirmed ticker, exchange, sector, market cap, and quarterly financials makes thorough risk assessment structurally limited. ---...